Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca

Providing technical support to the UHC agency in Senegal to institutionalise HTA.

(Reuters) – At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.But a string of failed attempts – punctuated by a 2007 trial in which a Merck vaccine appeared to make p

(Reuters) – Scientists have grown a drug to treat a rare genetic disease inside corn plants, potentially offering a cheaper way to manufacture a treatment that currently costs hundreds of thousands of dollars a year for each patient.The move marks an advance for the emerging field of molecular farmi

Attention Deficit and Hyperactivity Disorder (ADHD) is one of the health problems that affect learning, behavior, child development and sociability of school children. If ADHD is detected early and the correct treatment is provided, a patient can recover from the disease and live a normal life. ADHD screening measures currently used have diversity

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium

Vietnam visit 30th and 31st May 2017It feels good to see familiar faces when you are in a new place and I felt the same meeting officials from Health Strategy Planning Institution (HSPI), Ministry of Health of Vietnam once again. I had met them earlier during the HTAsiaLink conference held in April

I (the author of the blog) got to learn a lot about three things while discussions on these potential topics were on-going. Firstly, I got to know the uniqueness of the Vietnamese Health System and how they are trying to incorporate HTA and pharmacoeconomics in their current system, secondly I learn